$6.03
3.98%
Nasdaq, Sep 19, 03:30 pm CET
ISIN
VGG7185A1286
Symbol
PRTG

Portage Biotech Inc Stock price

$6.30
-2.81 30.85% 1M
+2.10 50.00% 6M
+1.13 21.86% YTD
-1.51 19.33% 1Y
-131.10 95.41% 3Y
-188.70 96.77% 5Y
-418.70 98.52% 10Y
-2,633.70 99.76% 20Y
Nasdaq, Closing price Mon, Sep 22 2025
+0.23 3.79%
ISIN
VGG7185A1286
Symbol
PRTG
Industry

Key metrics

Basic
Market capitalization
-
Enterprise Value
-
Net debt
positive
Cash
$1.7m
Shares outstanding
1.7m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
-
P/B
-
Financial Health
Equity Ratio
-5.5%
Return on Equity
5,501.6%
ROCE
-1,051.0%
ROIC
-9,895.7%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-11.8m | -
EBIT
$-11.9m | $-18.8m
Net Income
$-9.8m | $-880.0k
Free Cash Flow
$-5.5m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
35.0% | -
EBIT
34.9% | -153.2%
Net Income
87.0% | 87.0%
Free Cash Flow
61.8%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-8.3
FCF per Share
$-3.3
Short interest
4.2%
Employees
4
Rev per Employee
$0.0
Show more

Is Portage Biotech Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,013 stocks worldwide.

Portage Biotech Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Portage Biotech Inc forecast:

3x Hold
50%
3x Sell
50%

Analyst Opinions

6 Analysts have issued a Portage Biotech Inc forecast:

Hold
50%
Sell
50%

Financial data from Portage Biotech Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 6.67 6.67
18% 18%
-
- Research and Development Expense 5.16 5.16
59% 59%
-
-12 -12
35% 35%
-
- Depreciation and Amortization 0.05 0.05
0% 0%
-
EBIT (Operating Income) EBIT -12 -12
35% 35%
-
Net Profit -9.78 -9.78
87% 87%
-

In millions USD.

Don't miss a Thing! We will send you all news about Portage Biotech Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Portage Biotech Inc Stock News

Neutral
GlobeNewsWire
20 days ago
AlphaTON Capital Unlocks Public Market Access to Toncoin (TON) and Telegram's Billion-User Ecosystem Brittany Kaiser, pioneer in data protection, digital assets, and the public equity markets appointed Chief Executive Officer and Board Member Formerly Portage Biotech Inc. (Nasdaq: PRTG), Renamed AlphaTON Capital Corp with new ticker symbol “ATON” effective as of the opening of the market on Sep...
Neutral
GlobeNewsWire
20 days ago
DOVER, DE, Sept. 03, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Unlocks Public Market Access to Toncoin (TON) and Telegram's Billion-User Ecosystem Brittany Kaiser, pioneer in data protection, digital assets, and the public equity markets appointed Chief Executive Officer and Board Member Formerly Portage Biotech Inc. (Nasdaq: PRTG), renamed AlphaTON Capital Corp with new ticker symbol “ATON” ef...
Neutral
GlobeNewsWire
about 2 months ago
DOVER, Del., July 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company formed under the laws of the British Virgin Islands, with a portfolio of novel multi-targeted therapies for use as monotherapy and in combination, today reported its financial results for the fiscal year ended March 31, 2025.
More Portage Biotech Inc News

Company Profile

Portage Biotech, Inc. is a biotechnology company, which enables research and development to produce clinical programs and maximize potential returns. Its portfolio includes subsidiary companies, whose products or technologies have established scientific rationales, including intratumorals, nanoparticles, liposomes, aptamers, cell penetrating peptides, and virus-like particles. The firm provides funding, strategic business and clinical counsel, and shared services to treat different types of cancers. The company was founded by Gregory H. Bailey in 1973 and is headquartered in Road Town, British Virgin Islands.

Head office Virgin Islands, British
CEO Alexander Pickett
Employees 4
Founded 1973
Website portagebiotech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today